SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,000 | -66.7% | 144 | -7.1% | 0.00% | – |
| Q4 2021 | $6,000 | -96.5% | 155 | – | 0.00% | -100.0% |
| Q3 2021 | $170,000 | +7.6% | 0 | – | 0.08% | +40.4% |
| Q2 2021 | $158,000 | +56.4% | 0 | -100.0% | 0.06% | +2750.0% |
| Q1 2021 | $101,000 | +2425.0% | 1 | -96.2% | 0.00% | -99.8% |
| Q2 2020 | $4,000 | -99.3% | 26 | +420.0% | 1.23% | +61250.0% |
| Q1 2020 | $547,000 | +379.8% | 5 | -72.2% | 0.00% | -97.5% |
| Q4 2019 | $114,000 | +5600.0% | 18 | -10.0% | 0.08% | +3850.0% |
| Q3 2019 | $2,000 | +100.0% | 20 | 0.0% | 0.00% | +100.0% |
| Q2 2019 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,000 | 0.0% | 20 | -4.8% | 0.00% | 0.0% |
| Q3 2018 | $1,000 | -50.0% | 21 | -4.5% | 0.00% | -50.0% |
| Q2 2018 | $2,000 | +100.0% | 22 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $1,000 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |